Reusable rockets: who has achieved what so far?

LandSpace's Zhuque-3 reusable stainless-steel rocket completed a debut launch but failed to achieve a successful vertical landing of its main stage, underscoring the challenges in orbital booster recovery. If LandSpace can achieve consistent recovery it would be the first Chinese company and only the third globally after SpaceX and Blue Origin to reuse an orbital main stage; the piece contextualises this against incumbents (SpaceX's 300+ landings and 200+ reflights) and other players (Rocket Lab, Blue Origin, ISRO, European Themis and several Chinese firms) conducting hop tests or suborbital recoveries. The development is technologically significant for asset reusability but, given the failed landing and limited immediate commercial metrics, is unlikely to be a near-term market mover.

Analysis

Market structure: Successful reuse compresses marginal launch pricing and benefits vertically integrated, high‑cadence players (SpaceX, Blue Origin/New Glenn, Rocket Lab). If LandSpace cracks reliable recovery at scale, expect intensified price competition in LEO launches and 30–60% downward pressure on per‑kg launch prices over 2–5 years, advantaging satellite OEMs and constellation sponsors (e.g., AMZN’s Project Kuiper). Incumbent state providers and small one‑off launchers face margin erosion and consolidation risk.

Risk assessment: Near term (days–weeks) volatility will be driven by PR, funding announcements and any follow-on Chinese tests; medium term (3–12 months) contract awards and export/regulatory moves matter; long term (2–5 years) is technology scale and logistics (recovery ships, landing zones). Tail risks: Chinese/US export controls, a major pad/sea recovery failure causing insurer pullback, or state subsidy protectionism; hidden dependencies include ground infrastructure and engine life‑cycle supply chains.

Trade implications: Favor equities exposed to higher launch cadence (smallsat suppliers, select launchers) and defense primes that win government space spend if Chinese capability grows. Use asymmetric option structures to express idiosyncratic upside in RKLB/AMZN while capping downside; avoid financing or buying equity in private Chinese launchers until operational repeatability is proven (2 consecutive successful orbital recoveries).

Contrarian angles: Market consensus underestimates the time and capital needed to commercialize reuse at scale — early failures often precede dominance (SpaceX precedent) but many challengers fail. The reaction could be both overdone (hype around a single launch) and underdone (structural shift if LandSpace replicates success), so size exposures small (1–3% per idea) and ladder increases only on demonstrated repeatability or multimission reuse metrics.

Key Decisions for Investors

• Establish a tactical 1.5% portfolio long in Rocket Lab (RKLB) within 2 weeks to capture small‑sat launch share and potential re‑rating; set a stop loss at -25% and a 12‑month target +60% (trim by 50% on a 40% gain).
• Buy a 12‑month call spread on AMZN sized to 1–2% portfolio risk (buy 10% OTM calls and sell 30% OTM calls) to express optionality from improved New Glenn/Project Kuiper launch cadence; close on a 25% premium capture or upon Kuiper first‑shell deployment confirmation within 12 months.
• Add 1% each to RTX and LMT (total 2%) as defensive/beneficiary exposure to increased government space/defense spending over 6–24 months; reduce if either company’s space backlog declines >15% quarter‑over‑quarter.
• Execute an options play: buy 3‑month RKLB 30–50% OTM call spreads sized to 0.5–1% portfolio downside to speculate on positive reuse test news; halve position if implied volatility rises >40% in 30 days or put a hard 25% max loss.
• Avoid direct equity or debt exposure to Chinese private launchers (e.g., LandSpace, Deep Blue Aerospace) until they complete 2 consecutive successful orbital booster recoveries and receive clear MIIT/CSAR safety approvals (review after 90 days post‑second recovery).